Volume 11, Issue 2

June 2012
(18) Review, (1) Article - Comment, (1) Editorial

Editorial

Editorial
  • Talha Müezzinoglu
Bull Urooncol 2012; 11: 0-0

Review

Nomograms for prostate cancer: which and when to use
  • Saadettin Eskiçorapçı
  • Deniz Bolat
Bull Urooncol 2012; 11: 85-91
What is the best cutoff value of PSA in detection of prostate cancer
  • Hakan Gemalmaz
Bull Urooncol 2012; 11: 92-95
NON-PSA biomarkers for prostate cancer
  • Yarkın Kamil Yakupoğlu
  • Yakup Bostancı
  • Ender Özden
Bull Urooncol 2012; 11: 96-102
Repeat prostate biopsy: who, when, how?
  • Hayrettin Şahin
Bull Urooncol 2012; 11: 103-107
Current status of pain control in trus-guided prostate biopsy
  • İlker Seçkiner
  • Ömer Bayrak
Bull Urooncol 2012; 11: 108-113
Active surveillance for localized prostate cancer
  • İlker Tınay
  • Levent Türkeri
Bull Urooncol 2012; 11: 114-118
Surgical technique of nerve sparing radical prostatectomy and periprostatic field anatomy
  • Ali Cansu Bozacı
  • Bülent Akdoğan
  • Haluk Özen
Bull Urooncol 2012; 11: 119-123
Current surgical approaches in local invasive prostate cancer: urologist approach
  • Zafer Kozacıoğlu
  • Bülent Günlüsoy
Bull Urooncol 2012; 11: 124-128
Current treatment approaches in locally advanced prostate cancer: a radiation oncologist perspective
  • Ömür Karakoyun Çelik
Bull Urooncol 2012; 11: 129-133
Management of recurrences after radiation therapy used for curative intent in prostate cancer
  • Yılören Tanıdır
  • Levent Türkeri
Bull Urooncol 2012; 11: 134-141
Management of infravesical strictures after radical retropubic prostatectomy
  • Mustafa Karalar
  • İbrahim Keleş
  • Mutlu Ateş
Bull Urooncol 2012; 11: 142-145
Laparo-Endoscopic Single Site (LESS) radical prostatectomy: does port number decrease?
  • Bircan Mutlu
  • Volkan Tuğcu
Bull Urooncol 2012; 11: 146-149
Prostate cancer in the era of robotic surgery
  • Çag Çal
Bull Urooncol 2012; 11: 150-155
Immunotherapy for the treatment of castration resistant prostate cancer: sipuleucel-T
  • Güven Aslan
Bull Urooncol 2012; 11: 156-158
New treatment stragies in metastatic castration resistant prostate cancer: Re-Docetaxel, Abiraterone asetate, Cabazitaxel, MDV 3100
  • Sıtkı Ün
  • Ferruh Zorlu
Bull Urooncol 2012; 11: 159-163
Update in the management of skeletal related events for metastatic prostate cancer: Denosumab, Alfaradin
  • Serdar Çelik
  • Uğur Mungan
Bull Urooncol 2012; 11: 164-167
The significance of tertiary Gleason pattern in prostate cancer
  • H. Hüseyin Tavukçu
  • Polat Türker
Bull Urooncol 2012; 11: 168-172
Nursing interventions in patients receiving Taxan Chemotherapy
  • Yeter Kırdal
Bull Urooncol 2012; 11: 173-177

About Journal

Forms

Useful Links

Applications